Weihong Wang

Jan 1, 2024 | biopharminternational.com | Weihong Wang

Cell-based therapeutics are defined as “articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer into a human recipient” as per Code of Federal Regulations Title 21, Part 1271.3(d) (1). With their unique mechanism of action, cell therapy products hold the potential to treat many diseases that are refractory to current remedies in therapeutic areas such as regenerative medicine, immunotherapy, and cancer therapy.

Jul 27, 2023 | mdpi.com | Xia Wu |Pan Li |Weihong Wang |Jie Xu

Open AccessArticlebyXia Wu 1,2,†, Pan Li 1,2,†, Weihong Wang 1,2,†, Jie Xu 1,2, Rujun Ai 1,2, Quan Wen 1,2, Bota Cui 1,2 and Faming Zhang 1,2,* 1Department of Microbiota Medicine, Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China2Key Lab of Holistic Integrative Enterology, Nanjing Medical University, Nanjing 210011, China*Author to whom correspondence should be addressed. †These authors contributed equally to this work.